SHP-2 phosphatase activity is required for PECAM-1-dependent cell motility

American Journal of Physiology - Cell Physiology

Volumn 299, Issue 4, 2010, Pages

  Zhu, Jing Xu ^a   Cao, Gaoyuan ^a   Williams, James T ^a   DeLisser, Horace M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Angiogenesis; Leukocyte transendothelial migration; Mitogen activated protein kinase

Indexed keywords

ADAPTOR PROTEIN; CD31 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN; PROTEIN TYROSINE PHOSPHATASE SHP 2; SCAFFOLD PROTEIN;

ANGIOGENESIS; ARTICLE; CATALYSIS; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME RELEASE; FILOPODIUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; ANIMAL; CELL LINE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

ANIMALS; ANTIGENS, CD31; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MUTAGENESIS, SITE-DIRECTED; NEOVASCULARIZATION, PHYSIOLOGIC; PAXILLIN; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; SIGNAL TRANSDUCTION;

EID: 77957661937     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00436.2009     Document Type: Article

References (52)

1. Araki T, Nawa H, Neel BG. Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors. J Biol Chem 278: 41677-41684, 2003. (Pubitemid 37310425)
2. Barford D, Neel BG. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2. Structure 6:249-254, 1998. (Pubitemid 28159307)
3. Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84: 869-901, 2004. (Pubitemid 38823769)
4. Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res 64:8816-8820, 2004. (Pubitemid 39665483)
5. Billadeau DD, Leibson PJ. ITAMs versus ITIMs: striking a balance during cell regulation. J Clin Invest 109: 161-168, 2002.
6. Brahmbhatt AA, Klemke RL. ERK and RhoA differentially regulate pseudopodia growth and retraction during chemotaxis. J Biol Chem 278: 13016-13025, 2003.
7. Cao MY, Huber M, Beauchemin N, Famiglietti J, Albelda SM, Veillette A. Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases. J Biol Chem 273: 15765-15772, 1998. (Pubitemid 28298197)
8. Cao G, O'Brien CD, Zhou Z, Sanders SM, Greenbaum JN, Makrigiannakis A, DeLisser HM. The involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol Cell Physiol 282: C1181-C1190, 2002. (Pubitemid 34663126)
9. Cao G, Fehrenbach M, Williams J, Finklestein J, Zhu JX, DeLisser HM. Angiogenesis in PECAM-1-null mice. Am J Pathol 175: 903-915, 2009.
10. Carrithers M, Tandon S, Canosa S, Michaud M, Graesser D, Madri JA. Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol 166: 185-196, 2005.
11. Chan G, Kalaitzidis D, Neel BG. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev 27: 179-192, 2008.
12. Chang L, Karin M. Mammalian MAP kinase signaling cascades. Nature 410: 37-40, 2001.
13. Chen L, Sung S, Yip LR, Lawrence HR, Ren Y, Guida WC, Sebti SN, Lawrence NJ, Wu J. Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor. Mol Pharmacol 70: 562-570, 2006.
14. Dance M, Montagner A, Salles JP, Yart A, Raynal P. The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway. Cell Signal 20: 453-459, 2008.
15. DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151: 671-677, 1997.
16. Dimaio TA, Wang S, Huang Q, Scheef EA, Sorenson CM, Sheibani N. Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice. Dev Biol 315: 72-88, 2008.
17. Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, Spellberg J, Luis de la Pompa J, Elia A, Wakeham A, Karan-Tamir B, Muller WA, Senaldi G, Zukowski MM, Mak TW. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 162: 3022-3030, 1999. (Pubitemid 29309332)
18. Fujiwara K. Platelet endothelial cell adhesion molecule-1 and mechano-transduction in vascular endothelial cells. J Intern Med 259: 373-380, 2006. (Pubitemid 43384228)
19. Garnacho C, Albelda SM, Muzykantov VR, Muro S. Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes. J Control Release 130: 226-33, 2008.
20. Gratzinger D, Canosa S, Engelhardt B, Madri JA. Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho. FASEB J 17: 1458-1469, 2003. (Pubitemid 36935661)
21. Gupton SL, Gertler FB. Filopodia: the fingers that do the walking. Sci STKE 400: re5, 2007.
22. Huang C, Jacobson Schaller, MD K. MAP kinases and cell migration. J Cell Sci 117: 4619-4628.
23. Ilan N, Madri JA. PECAM1: old friend, new partners. Curr Opin Cell Biol 15: 515-524, 2003. (Pubitemid 37176959)
24. Jackson DE, Ward CM, Wang R, Newman PJ. The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1- and integrin-mediated cellular signaling. J Biol Chem 272: 6986-6993, 1997. (Pubitemid 27166399)
25. Jackson DE. The unfolding tale of PECAM-1. FEBS Lett 540: 7-14, 2003.
26. Ji G, O'Brien CD, Feldman M, Manevich Y, Lim P, Sun J, Albelda SM, Kotlikoff MI. PECAM-1 (CD31) regulates a hydrogen peroxide-activated nonselective cation channel in endothelial cells. J Cell Biol 157: 173-84, 2002. (Pubitemid 34847839)
27. Kogata N, Masuda M, Kamioka Y, Yamagishi A, Endo A, Okada M, Mochizuki N. Identification of Fer tyrosine kinase localized on microtubules as a platelet endothelial cell adhesion molecule-1 phosphorylating kinase in vascular endothelial cells. Mol Biol Cell 14: 3553-3564, 2003. (Pubitemid 37151608)
28. Kondo S, Scheef EA, Sheibani N, Sorenson CM. PECAM-1 isoform-specific regulation of kidney endothelial cell migration and capillary morphogenesis. Am J Physiol Cell Physiol 292: C2070-C2083, 2007. (Pubitemid 47080533)
29. Loh ML, Vattikuti S, Schubbert S, Reynolds MG, Carlson E, Lieuw KH, Cheng JW, Lee CM, Stokoe D, Bonifas JM, Curtiss NP, Gotlib J, Meshinchi S, Le Beau MM, Emanuel PD, Shannon KM. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103: 2325-2331, 2004. (Pubitemid 38326253)
30. Lu TT, Barreuther M, Davis S, Madri JA. Platelet endothelial cell adhesion molecule-1 is phosphorylatable by c-Src, binds Src-Src homology 2 domain, and exhibits immunoreceptor tyrosine-based activation motif-like properties. J Biol Chem 272: 14442-14446, 1997. (Pubitemid 27232863)
31. Maas M, Stapleton M, Bergom C, Mattson DL, Newman DK, Newman PJ. Endothelial cell PECAM-1 confers protection against endotoxic shock. Am J Physiol Heart Circ Physiol 288: H159-H164, 2005. (Pubitemid 40023843)
32. Mattila PK, Lappalainen P. Filopodia: molecular architecture and cellular functions. Nat Rev Mol Cell Biol 9: 446-454, 2008. (Pubitemid 351733400)
33. Muzykantov VR, Christofidou-Solomidou M, Balyasnikova I, Harshaw DW, Schultz L, Fisher AB, Albelda SM. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci USA 96:2379-2384, 1999. (Pubitemid 29117923)
34. Newman PJ. The biology of PECAM-1. J Clin Invest 99: 3-8, 1997.
35. O'Brien C, Cao G, Makringiannakis A, DeLisser HM. The Role of immunoreceptor tyrosine-based inhibitory motifs of platelet endothelial cell adhesion molecule (PECAM-1) in PECAM-1 dependent cell migration. Am J Physiol Cell Physiol 287: C1103-C1113, 2004.
36. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 290: 84-89, 2000.
37. Ren Y, Meng S, Mei L, Zhao ZJ, Jove R, Wu J. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor. J Biol Chem 279: 8497-8505, 2005. (Pubitemid 38294743)
38. Sagawa K, Kimura T, Swieter M, Siraganian RP. The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphylated adhesion molecule PECAM-1 (CD31). J Biol Chem 272: 31086-31091, 1997.
39. Saxton TM, Henkemeyer M, Gasca S, Shen R, Rossi DJ, Shalaby F, Feng GS, Pawson T. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J 16: 2352-2364, 1997.
40. Smythe WR, Hwang HC, Amin KM, Eck SL, Davidson BL, Wilson JM, Kaiser LR, Albelda SM. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasm: an effective in vitro drug sensitization system. Cancer Res 54: 2055-2059, 1994.
41. Solowiej A, Biswas P, Graesser D, Madri JA. Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol 162: 953-962, 2003.
42. Sun J, Paddock C, Shubert J, Zhang HB, Amin K, Newman PJ, Albelda SM. Contributions of the extracellular and cytoplasmic domains of platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) in regulating cell-cell localization. J Cell Sci 113: 1459-1469, 2000.
43. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29: 465-468, 2001. (Pubitemid 34326699)
44. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hählen K, Hasle H, Licht JD, Gelb BD. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34: 148-150, 2003. (Pubitemid 36666923)
45. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 7: 833-846, 2006. (Pubitemid 44627477)
46. Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser HM, Schwartz MA. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437: 426-431, 2005.
47. Udell CM, Samayawardhena LA, Kawakami Y, Kawakami T, Craig AW. Fer and Fps/Fes participate in a Lyn-dependent pathway from FcepsilonRI to platelet-endothelial cell adhesion molecule 1 to limit mast cell activation. J Biol Chem 281: 20949-20957, 2006.
48. Wang S, Yu WM, Zhang W, McCrae KR, Neel BG, Qu CK. Noonan syndrome/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis. J Biol Chem 284: 913-20, 2009.
49. Wiewrodt R, Thomas AP, Cipelletti L, Christofidou-Solomidou M, Weitz DA, Feinstein SI, Schaffer D, Albelda SM, Koval M, Muzykantov VR. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood 99: 912-922, 2002. (Pubitemid 34525553)
50. Woodfin A, Voisin MB, Nourshargh S. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 27: 2514-2523, 2007. (Pubitemid 350158900)
51. Yang W, Klaman LD, Chen B, Araki T, Harada H, Thomas SM, George EL, Neel BG. An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev Cell 10: 317-327, 2006. (Pubitemid 43300089)
52. Zhou Z, Christofidou-Solomidou M, Garlanda C, DeLisser HM. Antibody against Murine PECAM-1 Inhibits Tumor Angiogenesis in Mice. Angiogenesis 3: 181-188, 1999. (Pubitemid 129644645)